Evidence map›Paper›PMID 30057807›Full record

ArticleCardiology research and practice2018

Emmanuel Valdés-Alvarado, Yeminia Valle, José Francisco Muñoz-Valle, Ilian Janet García-Gonzalez, Angelica Valdez-Haro, Hector Enrique Flores-Salinas, Jorge Manuel Pérez-Ibarra, Elena Sandoval-Pinto, Jorge Ramón Padilla-Gutiérrez

Open access · goldAbstract read
In one paragraph

Article in Cardiology research and practice, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 4 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Emmanuel Valdés-AlvaradoInstituto de Investigación en Ciencias Biomédicas, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Sierra Mojada 950, Col. Independencia, 44340 Guadalajara, JAL, Mexico.ORCID 0000-0001-6810-9203
Yeminia ValleInstituto de Investigación en Ciencias Biomédicas, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Sierra Mojada 950, Col. Independencia, 44340 Guadalajara, JAL, Mexico.ORCID 0000-0002-4940-022X
José Francisco Muñoz-ValleInstituto de Investigación en Ciencias Biomédicas, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Sierra Mojada 950, Col. Independencia, 44340 Guadalajara, JAL, Mexico.ORCID 0000-0002-2272-9260
Ilian Janet García-GonzalezInstituto de Investigación en Ciencias Biomédicas, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Sierra Mojada 950, Col. Independencia, 44340 Guadalajara, JAL, Mexico.ORCID 0000-0002-4814-9934
Angelica Valdez-HaroInstituto de Investigación en Ciencias Biomédicas, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Sierra Mojada 950, Col. Independencia, 44340 Guadalajara, JAL, Mexico.
Hector Enrique Flores-SalinasCentro Médico Nacional de Occidente (CMNO), IMSS, Independencia Oriente, 44340 Guadalajara, JAL, Mexico.
Jorge Manuel Pérez-IbarraEspecialidad de Cardiología, Centro Médico Nacional de Occidente (CMNO), IMSS, Independencia Oriente, 44340 Guadalajara, JAL, Mexico.
Elena Sandoval-PintoInstituto de Investigación en Ciencias Biomédicas, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Sierra Mojada 950, Col. Independencia, 44340 Guadalajara, JAL, Mexico.ORCID 0000-0003-4440-929X
Jorge Ramón Padilla-GutiérrezInstituto de Investigación en Ciencias Biomédicas, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Sierra Mojada 950, Col. Independencia, 44340 Guadalajara, JAL, Mexico.ORCID 0000-0002-0240-2797
Universidad de Guadalajara · MX

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Acute coronary syndrome (ACS) describes any condition characterized by myocardial ischaemia and reduction in blood flow. The physiopathological process of ACS is the atherosclerosis where MIF operates as a major regulator of inflammation. The aim of this study was to assess the mRNA expression of MIF gene and its serum levels in the clinical manifestations of ACS and unrelated individuals age- and sex-matched with patients as the control group (CG). All samples were run using the conditions indicated in TaqMan Gene Expression Assay protocol. Determination of MIF serum levels were performed by enzyme-linked immunosorbent assay and MIF ELISA Kit. ST-segment elevation myocardial infraction (STEMI) and non-ST-segment elevation myocardial infarction (NSTEMI) showed 0.8 and 0.88, respectively, less expression of

Identifiers

PMID30057807
PMCPMC6051124
OpenAlexW2810085745

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.